Skip to main content

New Products

  • Actavis seeks approval for generic opioid-dependence drug

    DUBLIN — Actavis is hoping to become the first to market a generic version of a drug used to treat patients who have become dependent on opioid drugs, triggering a lawsuit from the branded drug's manufacturer.

    The generic drug maker said it had filed a regulatory approval application with the Food and Drug Administration for buprenorphine hydrochloride and naloxone hydrochloride sublingual film in the 2-mg/0.5-mg and 8-mg/2-mg strengths. The drug is a generic version of Reckitt Benckiser's Suboxone.

  • FDA approves Teva antibiotic

    JERUSALEM — The Food and Drug Administration has approved a new generic drug from Teva Pharmaceutical Industries for treating eye infections, the company said.

    The Israeli drug maker announced the approval of the antibiotic drug tobramycin inhalation solution, a generic version of Novartis' Tobi.

    Tobi has sales of about $350 million during the 12-month period that ended in June, according to IMS Health.

     

  • FDA approves easy-to-use injectable methotrexate for RA, psoriasis, juvenile arthritis

    EWING, N.J. — The Food and Drug Administration has approved a new drug made by Antares Pharma for treating rheumatoid arthritis and psoriasis, the drug maker said Monday.

  • First new Hershey brand in 30 years draws on company's heritage

    HERSHEY, Pa. — The Hershey Co. plans to launch its first new candy brand in 30 years in January, the company said.

    Hershey announced the upcoming launch of Lancaster, a line of caramel soft cremes. The new brand is named after the Lancaster Caramel Co., Milton Hershey's original brand, and inspired by similar candies that he made more than 120 years ago at the Lancaster, Pa., company.

  • Sanofi: Nasacort first nasal corticosteroid available without a prescription

    PARIS — Allergy sufferers will have a new treatment option available to them by the spring allergy season. Sanofi on Friday announced that the Food and Drug Administration approved Nasacort Allergy 24HR nasal spray (triamcinolone intranasal) as an over-the-counter treatment for seasonal and year-round nasal allergies in adults and children 2 years of age and older. 

    Nasacort is the first and only nasal corticosteroid to be available without a prescription and will be marketed by Sanofi's consumer healthcare division, Chattem.

  • 'Warrior Training Bracelets' aim to inspire healthy living

    ALISO VIEJO, Calif. — A line of leather bracelets made by Endorphin Warrior aims to inspire wearers to lose weight and improve their health.

  • PharmaSmart, Rexall enter deal to integrate kiosk data, electronic patient records

    ROCHESTER, N.Y. — Health kiosk maker PharmaSmart International and Canadian retail pharmacy chain Rexall will combine PharmaSmart's biometric screening technology with Rexall's dispensing system, under a new partnership announced Monday.

  • Vitamin World now carrying U.K.'s Organic Doctor personal care line

    LONG ISLAND, N.Y. — Organic Doctor, a naturally inspired skin care line in the U.K., is now available exclusively at Vitamin World stores in the U.S. — marking the first time that the retailer has carried a line of personal care items.  

    The brand's lineup includes organic extract led ranges that are now available at more than 400 Vitamin World stores nationwide and on the Vitamin World website. Suggested product prices range from $5.49 to $24.99.

X
This ad will auto-close in 10 seconds